HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study [Original Articles]

Conclusions:
Dynamic assessment using implantable device sensors within HeartLogic by itself or in conjunction with NT-proBNP measurements can identify time-intervals when patients are at significantly increased risk of worsening HF and potentially better triage resources to this vulnerable patient population.

Clinical Trial Registration:
https://www.clinicaltrials.gov. Unique identifier: NCT01128166.

Source: Circulation: Heart Failure - July 12, 2018 Category: Cardiology Authors: Gardner, R. S., Singh, J. P., Stancak, B., Nair, D. G., Cao, M., Schulze, C., Thakur, P. H., An, Q., Wehrenberg, S., Hammill, E. F., Zhang, Y., Boehmer, J. P. Tags: Heart Failure, Prognosis Original Articles Source Type: research